The cell surface Notch ligand delta-like 3 (DLL3) inhibits Notch pathway activation and has shown to be expressed on the cell surface of several tumor types including gliomas where DLL3 expression inversely correlated with outcome (118, 119). Here, DLL3 is linked to glioma.